Gina Consylman
2017 - Ironwood Pharmaceuticals
In 2017, Gina Consylman earned a total compensation of $967.5K as Chief Financial Officer and Senior Vice President at Ironwood Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $185,000 |
|---|---|
| Salary | $334,263 |
| Stock Awards | $440,213 |
| Other | $8,040 |
| Total | $967,516 |
Consylman received $440.2K in stock awards, accounting for 45% of the total pay in 2017.
Consylman also received $185K in non-equity incentive plan, $334.3K in salary and $8K in other compensation.
Rankings
In 2017, Gina Consylman's compensation ranked 9,136th out of 14,666 executives tracked by ExecPay. In other words, Consylman earned more than 37.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,136 out of 14,666 | 38th |
Division Manufacturing | 3,509 out of 5,772 | 39th |
Major group Chemicals And Allied Products | 1,202 out of 2,075 | 42nd |
Industry group Drugs | 963 out of 1,731 | 44th |
Industry Pharmaceutical Preparations | 755 out of 1,333 | 43rd |
Source: SEC filing on April 26, 2019.
Consylman's colleagues
We found four more compensation records of executives who worked with Gina Consylman at Ironwood Pharmaceuticals in 2017.
News
bluebird bio CEO Andrew Obenshain receives $9.3M in 2021
May 2, 2022
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019